These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24114807)

  • 21. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
    Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
    J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FHL1-related myopathy may not be classified by reducing bodies in muscle biopsy.
    Chen T; Lu X; Shi Q; Guo J; Wang H; Wang Q; Yin X; Zhang Y; Pu C; Zhou D
    Neuromuscul Disord; 2020 Feb; 30(2):165-172. PubMed ID: 32001145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
    Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology.
    Pen AE; Nyegaard M; Fang M; Jiang H; Christensen R; Mølgaard H; Andersen H; Ulhøi BP; Østergaard JR; Væth S; Sommerlund M; de Brouwer AP; Zhang X; Jensen UB
    Eur J Med Genet; 2015 Apr; 58(4):222-9. PubMed ID: 25724586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1.
    Windpassinger C; Schoser B; Straub V; Hochmeister S; Noor A; Lohberger B; Farra N; Petek E; Schwarzbraun T; Ofner L; Löscher WN; Wagner K; Lochmüller H; Vincent JB; Quasthoff S
    Am J Hum Genet; 2008 Jan; 82(1):88-99. PubMed ID: 18179888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing body myopathy and other FHL1-related muscular disorders.
    Schessl J; Feldkirchner S; Kubny C; Schoser B
    Semin Pediatr Neurol; 2011 Dec; 18(4):257-63. PubMed ID: 22172421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy.
    Gueneau L; Bertrand AT; Jais JP; Salih MA; Stojkovic T; Wehnert M; Hoeltzenbein M; Spuler S; Saitoh S; Verschueren A; Tranchant C; Beuvin M; Lacene E; Romero NB; Heath S; Zelenika D; Voit T; Eymard B; Ben Yaou R; Bonne G
    Am J Hum Genet; 2009 Sep; 85(3):338-53. PubMed ID: 19716112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.
    D'Avila F; Meregalli M; Lupoli S; Barcella M; Orro A; De Santis F; Sitzia C; Farini A; D'Ursi P; Erratico S; Cristofani R; Milanesi L; Braga D; Cusi D; Poletti A; Barlassina C; Torrente Y
    J Muscle Res Cell Motil; 2016 Jun; 37(3):101-15. PubMed ID: 27443559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
    Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.
    Sarkozy A; Windpassinger C; Hudson J; Dougan CF; Lecky B; Hilton-Jones D; Eagle M; Charlton R; Barresi R; Lochmüller H; Bushby K; Straub V
    Eur J Hum Genet; 2011 Oct; 19(10):1038-44. PubMed ID: 21629301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture.
    Park YE; Kim DS; Shin JH
    Clin Neurol Neurosurg; 2019 May; 180():48-51. PubMed ID: 30928807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
    Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
    IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a Novel Four and a Half LIM Domain 1 Mutation in a Chinese Male Presented with Hypertrophic Cardiomyopathy and Mild Skeletal Muscle Hypertrophy.
    Zhang BQ; Si N; Liu DF
    Chin Med J (Engl); 2015 Aug; 128(16):2269-70. PubMed ID: 26265627
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.
    Chung WK; Kitner C; Maron BJ
    Cardiol Young; 2011 Jun; 21(3):345-8. PubMed ID: 21262074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.
    Keßler M; Kieltsch A; Kayvanpour E; Katus HA; Schoser B; Schessl J; Just S; Rottbauer W
    Neuromuscul Disord; 2018 Jun; 28(6):521-531. PubMed ID: 29735270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
    Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
    Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.
    Kubota A; Juanola-Falgarona M; Emmanuele V; Sanchez-Quintero MJ; Kariya S; Sera F; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2019 Jan; 28(2):209-219. PubMed ID: 30260394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1.
    Vignier N; Le Corvoisier P; Blard C; Sambin L; Azibani F; Schlossarek S; Delcayre C; Carrier L; Hittinger L; Su JB
    Fundam Clin Pharmacol; 2014 Jun; 28(3):249-56. PubMed ID: 23600722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.